Background/Aims: Recurrent acute kidney injury (AKI) is common among patients after a first hospitalized AKI. However, little is known about the prognosis of recurrent AKI episodes in chronic kidney disease (CKD) development, cardiovascular events and mortality. Methods: A retrospective study included patients admitted to our Hospital from 2000 to 2010. AKI was defined according to the Acute Dialysis Quality Initiative criteria. In the follow-up period after the first AKI episode, clinical, laboratory data and the number of repeated AKI episodes, etiology and severity were recorded. Results: Among the 359 AKI survivor patients included, 250 new AKI episodes were observed in 122 patients (34%). Variables independently associated to new episodes were: type 2 DM [OR 1.2, 95%CI 1.2-3.8, p=0.001], ischemic heart disease [OR 1.9; 95%CI 1.1-3.6, p=0.012], and SCr at the first AKI event>2,6 mg/dl [OR 1.2; 95%CI 1.03-1.42, p=0.02]. Development of CKD during four years follow-up was more frequent in patients with recurrent AKI, HR [2.2 (95% CI: 1.09-4.3, p=0.003)] and 44% of recurrent AKI patients who developed CKD occurred during the first 6 months after the initial event. Cardiovascular events were more frequent among patients with recurrent AKI patients than in those with one AKI episode (47.2% vs 24%, p=0.001). Mortality at 4 years was higher in the patient subgroup with several episodes of AKI as compared with those with a single episode [HR: 4.5 (95% CI 2.7-7.5) p<0.001]. Conclusion: Episodes of recurrent AKI have a high potential to be associated with relevant complications such as cardiovascular events, mortality and CKD development.
Introduction
Acute kidney injury (AKI) has an estimated incidence of 14.9 -49.6 per 1000 patient years and may affect an estimated 13-18% of hospitalised patients. Incidence is increasing, and expected to double during the next decade [1] [2] [3] [4] . AKI has been considered a self-limiting disease, with good prognosis when recovery is noted during admission [5] However, several studies have suggested that AKI episodes are associated with higher risk of developing chronic kidney disease (CKD), cardiovascular events and overall mortality [6] [7] , although the mechanisms underlying this association remains poorly understood [8] . Recently, there has been increasing recognition that even patients with AKI with complete recovery, remain at risk for long-term renal complications [9] [10] . There are emerging data that the lack of recovery of renal function after AKI is an important contributor to the prevalence and progression of CKD [7, 9] . It remains uncertain to what the extent the association between AKI and adverse outcomes is mediated by AKI itself or by the development of CKD [11] . Although studies have demonstrated an association between moderate to severe forms of AKI and subsequent renal complications, less is known about the prognostic implications of milder forms of AKI [12] . Surprisingly, nephrology referral after AKI, including several forms, is likely infrequent [13] .
Few studies have focused on outcomes of AKI survivors, especially the impact of new AKI episode in patients with full recovery after an initial AKI episode. Patients who are discharged after suffering from AKI may face a high risk of rehospitalisation and also sustain repeated episodes of kidney injury. Up to one-third of elderly patients hospitalized with AKI, are rehospitalized with recurrent AKI within the first 12 months [14, 15] . In diabetic patients, repeated episodes of AKI may occur in one third of patients who survive initial hospitalization, and each episode has a cumulative dose-response association and doubles the risk of reaching stage 4 CKD [16] .
Whereas the majority of AKI patients experience milder degrees of kidney injury, published studies mainly recruit the severe AKI forms [17] [18] [19] . Little is known about renal and cardiovascular prognosis in patients with mild degrees of kidney injury suffering from several AKI episodes.
Using a cohort of hospitalized patients from an AKI episode with complete recovery of renal function at hospital discharged, we sought to determine the impact of repeated AKI episodes in renal outcomes during 4 years follow-up. Furthermore, we aimed to identify risk factors for developing CKD, cardiovascular events and mortality in this group of patients.
Materials and Methods

Study Design and Data Collection
The study was conducted retrospectively, including patients with an AKI diagnosis in Hospital del Mar, a tertiary care and university affiliated hospital, between January 2000 and December 2010.
Inclusion criteria were: (1) age > 18 years, (2) AKI with full recovery of renal function at hospital discharge, (3) patients with at least one determination of serum creatinine (SCr) three months prior to admission, either in our center or in a relevant health area. The exclusion criteria were: (1) prior known chronic disease (CKD), (2) renal allograft recipients (3) obstructive cause of AKI by means of radiological examination (4) patients with complete remission of serum creatinine before 48 hours with fluid reposition, in an effort to eliminate under-resuscitated patients [20] .
Eligible patients were identified using hospital´s coding system with International Classification of Diseases (ICD-9) of AKI or/and acute tubular necrosis. After identifying these patients, medical records were reviewed to select patients with an AKI diagnosis according ADQI criteria as any of the following: increase in SCr by *0.3 mg/dl (*26.5 mmol/L) within 48 hours; or increase in SCr to *1.5 times baseline serum creatinine [21] . Patients with AKI diagnosis according AKI criteria with full recovery of renal function at discharge were enrolled.
AKI-patients were assigned to their worst RIFLE category for analysis purpose. Briefly, patients were classified into the "risk" category if serum creatinine increased 1.5-fold, or glomerular filtration rate (GFR) decreased 25%; "injury" if SCr increased 2-fold or GFR decreased 50% and "failure" if SCr increased 3-fold or GFR decreased 75% [22] . The outcome criteria of loss of renal function and ESRD was defined by the duration of AKI [23] . Urine output criteria were not used in diagnosis or staging because data were not available in most patients.
AKI etiology was determined by chart review, length of AKI was defined by the number of days AKI was present and complete recovery of kidney function was defined as return of serum creatinine baselines values.
Demographic data were collected, along with past medical history of diabetes mellitus (DM), arterial hypertension, ischemic heart disease and peripheral vascular disease. Laboratory data were also collected.
After first AKI episode and hospital discharge, the medical records of each patient during the next fouryears were thoroughly examined. Information about the occurrence of new AKI episodes (we both have access to inpatients and outpatient medical records), etiology (pharmacological treatment, interecurrent illness, etc) severity, and the need of hospitalization were also recorded. In addition, analytical data were also abstracted.
CKD, was defined and staged according KDIGO guidelines, as a decreased GFR (GFR ≤60 ml/min/1.73 m 2 ) present for >3 months [24] , were recorded, and cardiovascular events (acute coronary event, heart failure, stroke, transient ischemic attack, acute arterial occlusion) and mortality during this period was also registered.
Statistical Analysis
Descriptive analysis included the absolute frequencies for qualitative variables as well as the mean and standard deviation (SD) for quantitative variables. Bivariate comparisons of subjects who did or did not develop recurrent AKI episodes were made using t-tests and chi-squared tests, as appropriate. Overall rates of CKD, cardiovascular events and death were compared across patient groups by chi-squared test.
Multivariable models were constructed by applying backwards elimination to a set of candidate predictors until all predictors remaining had p values less than 0.05. Data are expressed as odds ratio (ORs) and 95% confidence intervals (CIs).
In patients with several AKI episodes, the Kaplan-Meier method was used to obtain probability curves of survival and developing CKD and Cox regression model were used to investigate the effect of recurrent AKI episodes on survival and CKD development.
Statistical analysis was performed using SPSS V 21.0(SPSS Inc., Chicago, IL) and STATA version 15 (STATA Corp, Texas, USA). A p value of less that 0.05 was considered statistically significant.
Ethics
This study is adhered to the Principles of Helsinki Declaration and was approved by the hospital's Ethics Committee (CEIC-IMAS). Written informed consent was not required because of the non-intervention and retrospective chart review design.
Results
Patient Characteristics
Between January 2000 and December 2010, 3492 patients were identified as AKI or/ and acute tubular necrosis by International Classification of Diseases (ICD.9) in our hospital. Of these, 456 patients had renal data function data prior to the episode of AKI and met the criteria for diagnosis of AKI according ADQI guidelines [21] . Among them, 359 patients showed complete recovery of kidney function at hospital discharge and were enrolled in our study. Two hundred and seventeen patients (60.4%) were men, the mean age was 64.7 years (SD±20years), and 96.1% were caucasian. The baseline characteristics of the study population and characteristics of the first AKI episode, are described in Table 1 . Mean baseline SCr was 0.99 mg/dl (SD±0.35mg/dl) and first AKI episode was moderate in severity, the mean SCr during AKI episode was 3.4 mg/dl (SD±2.4), according to ADQI classification, most of the patients were classified as Injury group, 153.6 patients (42.8%). Mean of AKI duration was 28.3 ±44 days and 36 patients (10%) needed intermittent and/or continuous renal replacement therapy. The most frequent etiology of AKI in our sample was ischemic AKI (41.7%), 53 patients (11, 6%) were classified as drug-induced nephrotoxicity, the most frequent toxic was non-steroidal anti-inflammatory Drugs (NSAIDs) in 12 patients, cisplatin treatment in 8 patients 6 patients developed AKI after iodinated contrast administration, and 27 patients were classified as nephrotoxicity due to different antibiotics.
Recurrent AKI
During the 4-year follow-up, we obtain data from 253 (70.4%) patients, while 106 patients (29.5%) were lost of follow-up; 122 (34%) patients experienced new AKI episodes while 131 (36.5%) did not. Of these 122 recurrent AKI patients, 65 patients (53.2%) experienced a second event after the initial one, 38 patients (31.1%) presented two further episodes after the initial one and 18 (14.7%) patients experienced three or more episodes after the initial one.
Among all patients with recurrent AKI episodes, 53.7 (44%) of them developed the second AKI episode during the first six months after initial hospital discharge, increasing to 70.7 patients (58%) at one year (Fig. 1) .
Differences between recurrent AKI-patients (>1-AKI episode) and 1 AKI patients, are described in Table 2 . The AKI episodes were generally mild in severity, with mean creatinine 2.7± 1.5 mg/dl, fifty-three patients (43.8%) were rehospitalized with recurrent AKI diagnosis, but 68 patients (56.2%) were managed care in basic health area without nephrologist referral.
Five recurrent AKI patients (4.2%) required renal replacement therapy and the most common etiology of recurrent AKI was ischemia (55%). The presence of the following variables were significantly associated with multiple AKI episodes: age (68.7±15 vs 62.4±21 years, p=0.03), type 2 DM (41.3% vs 25.2%, p= 0.002), ischemic heart disease (32.1% vs 19%, p=0.02), hypertension (67.8% vs 53%, p=0.015), peripheral vascular disease (33.6% vs 26.3%, p=0.002), and characteristics related to the initial AKI episode such as increased SCr (3.7±2.4 mg/dl vs 2.7±1.5 mg/dl, p=0.001) and renal replacement therapy need (38.9% vs 13.9% p=0.003) ( CKD Stages were significantly associated with SCr in the first AKI episode. SCr in patients who developed CKD-4 was significant higher than SCr in CKD-3 patients (4.5±2.4 mg/dl vs 2.9±1.6 mg/dl; p=0.03).
Occurrence of CKD at 4 years follow-up was significantly higher in patients with recurrent AKI than in those with only one AKI episode [61.8% vs 41%, p=0.002].
As shown in Fig. 2 , the subset of patients with several AKI episodes had more probability of develop CKD as compared to the group with a unique AKI episode at the end of follow-up, even after censoring for loss to follow-up and adjusted for significant covariates (age and sex). After a median follow-up of 4 years, the hazard ratio for CKD in AKI recurrent patients was: HR [ 2.2 (95% CI: 1.09-4.3, p=0.003)].50% of recurrent AKI patients who developed CKD, occurred among the 6 month and 1 year after the initial AKI event.
Cardiovascular Events and Mortality in recurrent AKI patients
During the 4-years follow-up period, 82 cardiovascular events were recorded in the overall sample, 53 (64.6%) events in recurrent AKI patients. The most frequent events were congestive heart failure (CHF) (23, 28%), 22 acute coronary events (26.8%), and 13 ischemic stroke (16%).
The mean time until appearance of the first cardiovascular event in recurrent AKI patient was 15.3±3.6 months; while in one-AKI patients, this period was 18.6± 11.8 months.
Cardiovascular events were more frequent in recurrent AKI patients than in those with one AKI episode (47.2% vs 24%, p=0.001). Among the recurrent AKI patients, cardiovascular events were significantly higher in older ones (75.4±10 vs 62.9±16 years old; p=0.002), type 2 DM (60.4% VS 30.9%, p=0.003), arterial hypertension (89.6% vs 50.9%, p=0.001), and Overall, seventy-seven patients (34.7%) died during 4 years follow-up after the first AKI episode. The most common cause of death was a cardiovascular event (n=38, 33%), followed by malignancies (n=27, 23.7%), and infections (n=25, 21.9%). The meant time until death in AKI recurrent patient, after first AKI episode, was 25.8±22.1 months. Mortality at 4 years was higher in the subgroup with several episodes of AKI as compared with patients with a single episode (53.5% vs 19% respectively, p=0.001).
As shown in Fig. 3 , the subset of patients with several AKI episodes had less probability of surviving as compared to the group with a unique AKI episode at the end of follow-up, even after censoring for loss to follow-up and adjusted for significant covariates, Cox regression model showed high relative risk for mortality in recurrent AKI patients [HR: 4.5 (95% CI 2.7-7.5) p<0.001]. A composite variable, called MARCE, was made up of patients who developed CKD and/or suffered a cardiovascular event and/or die from cardiovascular disease during the 4-years follow-up period. Patients were classified according to the appearance of recidivant AKI as compared to a single AKI episode. Survival analyses showed (Fig. 4) that the subset of patients with several AKI episodes increased MARCE at 4 years of follow-up, as compared to the group with a unique AKI episode. Cox regression model showed high relative risk of MARCE in recurrent AKI patients [HR: 30.8 (95% CI 22.0-39.6), p<0.001)].
Discussion
Our results showed that AKI survivors with complete renal recovery are at risk for new AKI episodes mainly during the first year after the initial episode. These recurrent AKI episodes have a strong impact on renal outcomes and patient survival. Recently published data, identified AKI as a potentially and preventable risk factor for CKD [12, 25] . Early studies found an increased risk for CKD, including ESRD following an episode of dialysis-requiring AKI [26] [27] [28] and later studies have shown a similar association between non-dialysis AKI and CKD development, even after apparent renal recovery [7, 9] . However, few studies have focused in patients with recurrent episodes of milder forms of AKI.
We also demonstrated that repeated episodes of AKI occur in about one third of AKI patients who survive initial episode. In addition, type 2 DM, ischemic heart disease, and the severity of the initial AKI episode were identified as risk factors for recurrent AKI. In our work, recurrent AKI episode were mild in severity (mean creatinine 2.7 mg/dl) and as mentioned above, recurrent AKI was most common in the first year after hospitalization, 44% of the episodes occurred within the six months after first AKI and the most common etiology was ischemic insult, concordant with previous reports [15] This early recurrence might be ascribed to previous subclinical damage which itself make the kidneys vulnerable to different insults, as has been previously reported [29] [30] [31] [32] [33] .
In vitro studies demonstrate a prolonged inflammatory and remodeling response in renal tissues following an insult, providing a biologically plausible basis for the transition from AKI to CKD [4, 29, [34] [35] [36] .
Our results showed that mild-AKI recurrent episodes, have a high impact on CKD development, not only in the short-term, but also in the long-term (four years). Thus recurrent AKI episodes confer 2, 2 times more risk for CKD development [2.2 (95% CI: 1.09-4.3, p=0.003)]. Severity of AKI predicts risk for CKD in a creatinine-dependent manner, SCr in AKI first episode in patients who developed CKD-4 was significant higher than SCr in patients who developed CKD-3 patients (4.5±2.4 mg/dl vs 2.9±1.6 mg/dl; p=0.003).
We also found a higher mortality in recurrent AKI patients. Thus, repeat AKI episodes confered 4.5 times more risk for mortality in the follow-up period [HR: 4.5 (95% CI 2.7-7.5) p<0.001], concordant with previous report [6] and 3-fold increase in the risk of cardiovascular events compared with those with a single AKI episode. Cardiovascular events were significant higher in recurrent AKI patients (63.7% vs 36.6%, p=0.001) than in one AKI event patients; cardiovascular events in recurrent AKI patients were significant higher in patients with the classical risk factors such as diabetes, arterial hypertension, ischemic heart disease, and age. These results were reinforced by analysis of MARCE, repeat AKI episodes confer 30.8 times more risk for develop MARCE, this means that AKI recurrent patients have more risk for developing CKD and/or suffer a cardiovascular event or/and die of cardiovascular disease, during 4-years follow-up after the initial AKI.
In our work, less than 50% of the patients were referred to a nephrologist in the second AKI event. The optimal care following AKI remains to be defined and the transition care may be an opportunity to prevent further AKI episodes, loss of kidney function and its sequelae [37] .
Because new AKI episodes or CKD development results in a substantial healthcare burden, these data could help clinicians to design strategic plans for following-up AKI patients after hospital discharge [13] . Our results suggest that more efficient approach to identify patients at AKI risk are needed, this may be especially appropriate during the first year following the first event, when most recurrent AKI episodes have been diagnosed.
Our study has some limitations, in particular the retrospective nature of the assessment, and the small sample, but our results are in agreement with two previous studies focused in recurrent AKI [10, 26] .
The strengths of our study include the long duration of follow-up, the detailed participant clinical data, and the accurate diagnosis of AKI through ADQI guidelines. Another added values are the record of baseline SCr before the first episode, to increase specificity in comparison to the use of ICD-9 alone, and a very strict definition of recovery after AKI, even stricter than the usual recommendations in some studies or guidelines [9, 11, 38] . In this way, we avoided the inclusion of underdiagnosed CKD patients.
Conclusion
Milder recurrent AKI episodes were associated with CKD development, cardiovascular events and mortality compared to patients with only one AKI episode. Improvement in patient management after recovering from an AKI episode and hospital discharge may mitigate those negative outcomes.
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